Luspatercept is a recombinant fusion protein that works by binding and inhibiting the ligands of the TGFβ superfamily, interrupting TGFβ signaling, which is dysregulated in MDS [8]. The gene discussed is TGFB1; the disease is myelodysplastic syndrome.